Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 133   

Articles published

GSK 1,640.77 -6.73 (-0.41%)
price chart
Will GlaxoSmithKline plc (ADR) (GSK) Exhibit Growth After Patent Cliff?
Majority of the investors are skeptical about the future prospects of GlaxoSmithKline plc (ADR) (NYSE:GSK) due to its performance in 2015, as it was hit hard by the patent cliff.
GlaxoSmithKline to pay $20 mln to settle US foreign bribery cas...
WASHINGTON, Sept 30 GlaxoSmithKline Plc will pay $20 million to settle civil charges that it masked bribes to foreign officials in China by disguising them as legitimate travel, entertainment and marketing expenses, U.S.
GlaxoSmithKline plc 18.7% Potential Upside Indicated by Liberum Capital
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK had its stock rating noted as 'Resumes' with the recommendation being set at 'BUY' today by analysts at Liberum Capital.
GlaxoSmithKline plc (GSK) Given "Buy" Rating at Liberum Capital  The Cerbat Gem
GlaxoSmithKline plc (GSK) Price Target Lowered to GBX 1900 at Jefferies Group  BBNS
GlaxoSmithKline plc 12.3% Potential Upside Indicated by Deutsche Bank
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK had its stock rating noted as 'Retains' with the recommendation being set at 'HOLD' this morning by analysts at Deutsche Bank.
GlaxoSmithKline plc's (GSK) "Hold" Rating Reaffirmed at ...  Community Financial News
Bonds of GlaxoSmithKline, BAE Systems Among First BOE Purchases
Bonds of GlaxoSmithKline Plc, the U.K.'s largest drugmaker, were among those purchased by the Bank of England in the first week of its corporate note-buying program, according to people familiar with the matter.
GSK - GlaxoSmithKline plc: GSK intends to sell remaining holding in Aspen
GlaxoSmithKline has been an Aspen shareholder for 7 years. During this time Aspen's share price has risen approximately six fold from c.ZAR50 in May 2009 to ZAR317 today.
GlaxoSmithKline plc (NYSE:GSK) (GSK), Johnson & Johnson (NYSE:JNJ) Submit ...
GlaxoSmithKline plc (NYSE:GSK) (GSK) revealed on Monday that it has completed the Marketing Authorization Application (MAA) submission to the European Medicines Agency (EMA), seeking approval of the subcutaneous formulation of human ...
GlaxoSmithKline Plc (NYSE:GSK) Is Betting On A New Treatment Regime For HIV
GlaxoSmithKline Plc (NYSE:GSK) is betting on a new two-drug regimen to treat HIV, a move that if successful could see it surge ahead of its rival Gilead Sciences, Inc. (NASDAQ:GILD).
GlaxoSmithKline plc 10.5% Potential Upside Indicated by Goldman Sachs
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' today by analysts at Goldman Sachs.
GlaxoSmithKline plc (GSK) Given "Buy" Rating at Beaufort Securities  The Cerbat Gem
GSK - GlaxoSmithKline plc: GSK divests non-core assets to Aspen
GSK will divest its anaesthesia portfolio to Aspen for �180 million plus milestones of up to �100 million. In addition to this divestment, GSK and Aspen have entered into parallel agreements to terminate their collaboration in Sub-Saharan Africa and ...
Aspen to Buy Glaxo Drugs for $372 Million as Deal Spree Goes On  Bloomberg